Article and Video CATEGORIES

Cancer Journey

Search By

Assistant Professor of Medicine, Hospital of the University of Pennsylvania, and the Veteran’s Administration Medical Center

Lung Cancer Video Library 2020 - BAUML - Emerging Molecular Targets in NSCLC, RET Fusions
Lung Cancer Video Library 2020 - Emerging Molecular Targets in NSCLC, RET Fusions with Joshua Bauml MD
Author
Joshua Bauml, MD, Advisory Board Member, GRACE Faculty
Image
For this new addition to the GRACE Lung Cancer Video Library, Dr. Josh Bauml joins GRACE to discuss current updates in treatments for non small cell lung cancer.

In this video, Dr. Bauml discusses updated information on emerging molecular targets in nsclc - RET fusions.

 

To join the conversation, visit https://cancergrace.org/forum.

 

 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora